Table 3 Participant outcomes according to FAI, HAD, LiSat-11, Self-efficacy scale, FSS

FAI at inclusion

38^a

33^a

24^a

34^a

33^a

17

5

12

18

13

at follow-up (0–45)

36

14

9

34

30

11

9

30

23

19

HAD-A at inclusion

3

8

1

11

2

13

3

1

10

1

at follow up (0–21)

2

6

4

3

4

2

10

1

9

0

HAD-D at inclusion

1

5

1

1

8

11

2

0

11

1

at follow-up (0–21)

2

4

3

0

10

6

16

3

9

0

LiSat-11 at 4 weeks

6

4

5

4

5

6

2

3

3

4

at follow up (1–6)

5

5

4

5

4

5

1

4

5

4

Self-efficacy scale at 4 weeks

7.7

6.2

8.1

9.8

8.4

7.1

5.0

7.4

6.3

7.8

at follow-up (1–10)

8.8

7.4

8.0

9.7

8.9

6.6

5.3

8.8

7.7

7.9

FSS at 4 weeks

5.1

6.7

2.6

1.9

6.3

4.6

5.8

4.3

6.8

1.3

at follow-up (1–7)

4.8

6.4

1.0

2.9

5.7

6.0

7.0

4.0

6.4

2.2